Molecular mechanism of growth factor receptor expression in human microvascular endothelial cells.
人微血管内皮细胞生长因子受体表达的分子机制。
基本信息
- 批准号:06836014
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Oxygen radicals are generated under various pathologic condition including inflammation, ischemia reperfusion, sepsis and ultraviolet light irradiation, The vascular endothelium is one of the prime targets for oxidant injury in a variety of inflammatory conditions. It is reported that hypoxic or hyperoxic stress induces angiogenic signaling in human glioma cells. Among angiogenic factors, we especially focused on the mechanism of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) induction under various stress.1) The expression of VEGF has been implicated in brain tumor angiogenesis and the promoter region for VEGF gene conditions several SP-1 and AP-1 (c-fos/c-jun) binding motifs. Among 8 human glioma cell lines, cellular mRNA levels of transcription factors, SP-1 and AP-1 (c-fos/c-jun), were found to be closely correlated with those of VEGF.Our data indicate that VEGF gene expression by bFGF or TNF-alpha is mediated in part through the transcription factor SP-1, and that by hypoxia is mediated through the transcription factor AP-1.2) Another angiogeic factor is the cytokine, IL-8, that is produced at high levels in monocytes, macrophages and also human brain tumors. IL-8 induces cell migration of human umbilical endothelial cells, angiogenesis in rat cornea and tubular morphogenesis by microvascular endothelilal cells. Recent studies demonstrate that the IL-8 gene promoter region contains binding sites for AP-1 and NFxB.Moreover, co-administration of anti-IL-8 antibody inhibited tubular morphogenesis enhanced by H_2O_2, and IL-8 itself also enhanced formation of tube-like structures. H_2O_2 increased production of IL-8 in endothelial cells. Treatment with antisense NFkB oligonucleotide completely blcked the H_2O_2-dependent IL-8 production. Transcription factors SP-1, AP-1 and NFxB appeared to be involved in VEGF or IL-8 induction in glioma cells under various stress.
氧自由基是在各种病理状况下产生的,包括炎症,缺血再灌注,败血症和紫外线光照射,血管内皮是在多种炎症条件下氧化剂损伤的主要靶标之一。据报道,低氧或高氧应激会诱导人神经胶质瘤细胞中的血管生成信号传导。在血管生成因素中,我们特别关注血管内皮生长因子(VEGF)和白介素8(IL-8)在各种压力下的诱导机制。1)VEGF的表达与脑肿瘤血管生成有关,脑肿瘤血管生成与VEGF基因条件的启动子区域有关,VEGF基因条件几个SP-1和AP-1和AP-1(C-FOS/C-JUN)(C-1和C-JUN)的结合。在8种人神经胶质瘤细胞系中,发现转录因子的细胞mRNA水平SP-1和AP-1(c-fos/c-Jun)与VEGF的细胞密切相关。细胞因子,IL-8,在单核细胞,巨噬细胞和人脑肿瘤中以高水平产生。 IL-8诱导人脐带内皮细胞的细胞迁移,大鼠角膜中的血管生成以及微血管内皮细胞的管状形态发生。最近的研究表明,IL-8基因启动子区域含有用于AP-1和NFXB的结合位点。此外,抗IL-8抗体的共同给药抑制了H_2O_2增强的管状形态发生,而IL-8本身也增强了管类似管的结构的形成。 H_2O_2增加了内皮细胞中IL-8的产生。反义NFKB寡核苷酸的治疗完全使H_2O_2依赖性IL-8产生。转录因子SP-1,AP-1和NFXB似乎参与了各种应力下神经胶质瘤细胞中的VEGF或IL-8诱导。
项目成果
期刊论文数量(70)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Jimi,S.: "Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem." Biophys.Res.Commum.211. 476-483 (1995)
Jimi,S.:“牛血管生成素对牛内皮细胞中肾小管形态发生和纤溶酶原激活剂表达的调节。生物化学。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Ito: "Expression of tissue‐type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on matrigel." J.Cell.Physiol.(in press). (1994)
K.Ito:“组织型纤溶酶原激活剂及其抑制剂的表达与基质胶上人微血管内皮细胞的毛细血管网络的发育相结合。”(J.Cell.Physiol)(1994 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Kuwano: "Gann Monograph.on Cancer Research" CRC press, 23 (1994)
M.Kuwano:“江恩癌症研究专着”CRC press,23 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ONO Mayumi其他文献
ONO Mayumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ONO Mayumi', 18)}}的其他基金
Study on the Official Role of Goyo-Eshi in building of the Tokugawa Shogunate Collection
御代江士在德川幕府收藏建设中的官方角色研究
- 批准号:
16K02292 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the beginning of natural history science by the Edo shogunate and on roles of Goyo-eshi
江户幕府自然历史科学的开端及五代江士的作用研究
- 批准号:
25370150 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The critical role of an inflammatory cytokine IL-1 in tumor microenvironment on regulation of tumor angiogenesis and metastasis
肿瘤微环境中炎症细胞因子IL-1在调节肿瘤血管生成和转移中的关键作用
- 批准号:
23300350 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The critical role of inflammation in angiogenesis and malignant progression by cancer cells through altered tumor microenvironment
炎症通过改变肿瘤微环境在血管生成和癌细胞恶性进展中发挥关键作用
- 批准号:
19390089 - 财政年份:2007
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Involvement of VEGF receptors or inflammatory cytokines in tumor angiogenesis as a cancer therapy
VEGF 受体或炎症细胞因子参与肿瘤血管生成作为癌症治疗
- 批准号:
10557014 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Genetical and biochemical study on somatic cell mutants defective in EGF receptor.
EGF受体缺陷体细胞突变体的遗传学和生化研究。
- 批准号:
62570118 - 财政年份:1987
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Wip1/AP-1通路介导的CD8+/CD122+ Treg分化在移植排斥中的作用及机制研究
- 批准号:82302004
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HIV-1通过MAPK-Jun/AP-1信号通路促进M-MDSCs细胞扩增及其免疫抑制作用的研究
- 批准号:82360392
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
MLIP调控AP-1稳定性促进缺血性心力衰竭合并骨骼肌萎缩的机制研究
- 批准号:82370382
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于“煨脓长肉”法从IL-17R/MAPKs/AP-1轴调控巨噬细胞极化探讨润肌丹油促进糖尿病足溃疡愈合的物质基础与作用机制
- 批准号:82305253
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
YAP/AP-1复合物调控ER阳性乳腺癌内分泌耐药的分子机理研究
- 批准号:32370622
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Understanding polarized EGFR trafficking and signal regulation by RAB-10/8 and AP-1
了解 RAB-10/8 和 AP-1 的极化 EGFR 运输和信号调节
- 批准号:
489592 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Operating Grants
The roles of AP-1 pathway activation in NK cell development and exhaustion programming in AML
AP-1 通路激活在 NK 细胞发育和 AML 衰竭编程中的作用
- 批准号:
10751755 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Transcriptional Activation of p62 by the master antioxidant NRF2 in EBV latency
EBV潜伏期主要抗氧化剂NRF2对p62的转录激活
- 批准号:
10726975 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Selective targeting of a Rho GTPase mutant for peripheral T cell lymphoma treatment
选择性靶向 Rho GTPase 突变体治疗外周 T 细胞淋巴瘤
- 批准号:
10721439 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别: